Apollo Hospitals Enterprise Ltd. shares witnessed recovery of nearly 4% from lows as the stock hit an intraday high of Rs 377.70 after making a morning low of Rs 358.75 as the company’s management struck an optimistic tone in a media interaction following the announcement of its Q4FY26 earnings.
The management highlighted continued strong demand trends across healthcare services and expressed confidence in sustaining growth momentum going forward, which helped improve investor sentiment after the results announcement.
For the March quarter, Apollo Hospitals reported consolidated revenue of ₹6,605.5 crore, up 18.1% year-on-year from ₹5,592.2 crore in the corresponding quarter last year. The revenue performance came ahead of analyst estimates of ₹6,493 crore.
Net profit for Q4FY26 rose 35.9% YoY to ₹529.3 crore compared to ₹389.6 crore a year ago, while EBITDA increased 31.3% YoY to ₹1,011 crore from ₹770 crore.
The company’s EBITDA margin expanded 150 basis points to 15.3% versus 13.8% in the year-ago period, also exceeding analyst expectations of 14.7%.
Market participants were also encouraged by management commentary around operational strength, hospital occupancy trends and growth visibility across core healthcare businesses.
Apollo Hospitals continues to benefit from rising patient volumes, increased contribution from specialised treatments and improving operational efficiencies across its hospital network. Investors are also closely tracking expansion plans and the company’s broader digital healthcare ecosystem initiatives.
Apollo Hospitals remains one of India’s largest integrated healthcare providers with businesses spanning hospitals, diagnostics, pharmacies and digital health services.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.